GP’s are reportedly facing claims from insurance companies for overspending their budgets, which are imposed by the Healthcare ministry.
op in its domestic 1Q06 sales, which were down by 16.6% y/y. Lower reimbursements (since August 1) and claims from insurance companies may further depress the whole domestic market, which fell by 17.6% y/y in the 1Q06 (in terms of value) and drag Zentiva with it. Ultimately, the measures should support generic producers in the long-term but in the short-term the market domestic market conditions are not favourable putting pressure on Zentiva’s export activities.